Our study population was subject to selection bias, as it contained many patients with more common sarcoma subtypes and lacked patients with rarer histologic types, such as chordoma or clear cell sarcoma, which could potentially underestimate the correlation between B7-H3 positivity/expression and sarcoma subtypes. The gene discussed is CD276; the disease is clear cell sarcoma.